Is a complete BIT/BMED research report available?

No complete published report is available for bit/BMED (BIT/BMED) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

bit/BMED stock profile: metrics, valuation and analysis

Market cap	17.5B
Revenue (ttm)	2.6B
Net income (ttm)	1.3B
EPS (ttm)	€1.77
Shares out	740.9M
P/E (trailing)	13.4x
P/E (forward)	15.1x
Dividend	€1.30 (5.46%)
Volume	456,490
Beta	0.75

All BIT/BMED indicators

Market & fundamental data

Available fields

203

Groups with data

Currency

EUR

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Italy
Country code	IT
Employees	4,166
Employees Change	295%
Employees Change Percent	7.62
Exchange	Borsa Italiana
Financial currency	EUR
First seen	2026-05-10
Industry	Banks - Regional
Industry PE	12.64
Industry PE Fwd	11.78
Isin	IT0004776628
Last refreshed	2026-09-08
Market cap	EUR 17.5B
Price	EUR 23.23
Price currency	EUR
Rev Per Employee	614,601.54x
Sector	Financials
Sector PE	12.89
Sector PE Fwd	11.96
Sic	6200
Symbol	bit/BMED
Website	https://www.bancamediolanum.it

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.52%
FCF yield	4.13%
Forward P/E	15.08x
P/B ratio	3.82x
P/E ratio	13.36x
P/S ratio	6.83x
PE Ratio10 Y	11.06x
PE Ratio3 Y	9.47x
PE Ratio5 Y	9.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
FCF margin	28.24%
Gross Profit	EUR 2.6B
Net Income	EUR 1.3B
Net Income Growth	14.75%
Net Income Growth Q	19.39%
Net Income Growth Qo Q	1.13%
Net Income Growth Quarters	14%
Net Income Growth Years	3%
Net Income Growth3 Y	27.9%
Net Income Growth5 Y	18.95%
Pretax Margin	60.8%
Profit Margin	51.4%
Profit Per Employee	EUR 315,925
Profitable Quarters	EUR 30
Profitable Years	22
ROA	1.42
Roa5y	1.12
ROE	30.06
Roe5y	25.48

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	21.48%
Cagr1y	46.29%
Cagr3y	52.06%
Cagr5y	32.46%
Div CAGR10	15.34%
Div CAGR3	35.72%
Div CAGR5	115.86%
EPS Growth	15.09
EPS Growth Q	19.7
EPS Growth Quarters	14
EPS Growth Years	3
EPS Growth3 Y	27.9
EPS Growth5 Y	18.74
FCF Growth	-4.56%
FCF Growth3 Y	59.85%
FCF Growth5 Y	45.91%
OCF Growth	-5.84%
OCF Growth10 Y	16.79%
OCF Growth3 Y	54.01%
OCF Growth5 Y	43.79%
Revenue Growth	7.05x
Revenue Growth Q	29.03x
Revenue Growth Qo Q	19.92x
Revenue Growth Quarters	3x
Revenue Growth Years	3x
Revenue Growth3 Y	17.29x
Revenue Growth5 Y	12.71x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 99.1B
Cash	EUR 53.9B
Debt	EUR 5.1B
Debt FCF	EUR 7.11
Equity	EUR 4.6B
Liabilities	EUR 94.6B
Net Cash	EUR 48.8B
Net Cash By Market Cap	EUR 279
Net Cash Growth	19.44%
Net Debt Equity	EUR -10.65
Net Debt FCF	EUR -67.45
Tangible Book Value	EUR 4.4B
Tangible Book Value Per Share	EUR 5.89
WACC	6.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Working Capital	EUR -5.7B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.27%
Dividend Growth	25%
Dividend Growth Years	2%
Dividend per share	EUR 1.3
Dividend Years	6
Dividend Yield	5.46%
Ex Div Date	2026-04-20
Last Dividend	EUR 0.65
Payout Frequency	Semi-Annual
Payout Ratio	70.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	599.53%
1Y total return	46.25%
200-day SMA	20.03
3Y total return	251.7%
50-day SMA	23.28
50-day SMA vs 200-day SMA	50over200
5Y total return	307.73%
All Time High	24.54
All Time High Change	-5.34%
All Time High Date	2026-08-06
All Time Low	4.02
All Time Low Change	477.29%
All Time Low Date	2020-03-19
ATR	0.37
Beta	0.75
Beta1y	0.96
Beta2y	0.98
Ch YTD	19.31
High	23.65
High52	24.54
High52 Date	2026-08-06
High52ch	-5.34%
Low	23.23
Low52	15.99
Low52 Date	2026-03-23
Low52ch	45.28%
Ma50ch	-0.21%
Price vs 200-day SMA	16%
RSI	40.97
RSI Monthly	74.78
RSI Weekly	62.6
Sharpe ratio	1.56x
Sharpe Ratio3y	1.79x
Sharpe Ratio5y	1.08x
Sortino ratio	2.55
Sortino Ratio3y	2.88
Sortino Ratio5y	1.75
Total Return	5.73%
Tr YTD	23.4
Tr1m	-3.97%
Tr1w	-3.41%
Tr3m	18.82%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	519,092,551%
Shares Institutions	10.68%
Shares Out	740,863,917
Shares Yo Y	-0.27%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	571,136.15x
Bv Per Share	6.18
CAPEX	EUR -6.8M
Ch10y	263.3
Ch1m	-3.97
Ch1w	-3.41
Ch1y	36.81
Ch3m	18.82
Ch3y	181.2
Ch5y	163.3
Ch6m	36.97
Change	-1.65%
Change From Open	-1.78
Close	23.62
Days Gap	0.13
Dollar Volume	10,604,262.7
Earnings Date	2026-11-10
EPS	EUR 1.77
F Score	3
FCF	EUR 723.2M
FCF Per Share	EUR 0.98
Financing CF	-913,003,000
Fiscal Year End	December
Founded	1,982
Goodwill	125,625,000
Graham Number	15.45817
Graham Upside	-33.46
Income Tax	EUR 240.6M
Investing CF	-38,683,000
Is Primary Listing	1
Last Earnings Date	2026-07-30
Last Report Date	2026-06-30
Lynch Fair Value	EUR 33.11
Lynch Upside	42.52
Ma150	20.3
Ma150ch	14.41%
Ma20	24.01
Ma20ch	-3.24%
Net CF	-221,734,000
Next Earnings Date	2026-11-10
Open	23.65
P FCF Ratio	24.2
P OCF Ratio	23.97
Payment Date	2026-04-22
Position In Range	0
Ppne	202,298,000
Price Date	2026-09-07
Ptbv Ratio	4.01
Relative Volume	0.82x
Revenue	2,560,430,000x
Tax By Revenue	9.4x
Tax Rate	15.45%
Tr6m	41.67%
Volume	456,490

BIT/BMED (BIT/BMED)

Price

Financial snapshot

Fair-value bridge

Latest news · BIT/BMED

Valuation

Profitability

Trading

Next earnings

Sector percentile context

All BIT/BMED indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on BIT/BMED

Frequently asked questions